SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 39 filers reported holding SCPHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $551,024 | -59.3% | 77,391 | -41.7% | 0.00% | – |
| Q2 2023 | $1,352,773 | -50.5% | 132,755 | -55.9% | 0.00% | – |
| Q1 2023 | $2,731,458 | +140.6% | 301,153 | +90.2% | 0.00% | – |
| Q4 2022 | $1,135,061 | +175.5% | 158,307 | +150.7% | 0.00% | – |
| Q3 2022 | $412,000 | +17.7% | 63,158 | -13.0% | 0.00% | – |
| Q2 2022 | $350,000 | +51.5% | 72,623 | +78.5% | 0.00% | – |
| Q1 2022 | $231,000 | +165.5% | 40,689 | +246.0% | 0.00% | – |
| Q1 2020 | $87,000 | +29.9% | 11,759 | -33.6% | 0.00% | – |
| Q4 2018 | $67,000 | – | 17,711 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 3,561,474 | $17,166,000 | 4.25% |
| AIGH Capital Management LLC | 1,346,724 | $6,491,000 | 1.71% |
| Worth Venture Partners, LLC | 335,985 | $1,784,000 | 1.05% |
| Ikarian Capital, LLC | 884,008 | $4,261,000 | 0.78% |
| Orbimed Advisors | 4,797,148 | $23,122,000 | 0.42% |
| ARMISTICE CAPITAL, LLC | 2,700,000 | $13,014,000 | 0.23% |
| Sandy Cove Advisors, LLC | 10,592 | $51,000 | 0.05% |
| Belvedere Trading LLC | 239,219 | $1,270,000 | 0.04% |
| IPG Investment Advisors LLC | 14,300 | $69,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 132,200 | $637,000 | 0.02% |